10th Annual Glow Ride for Cystic Fibrosis Surpasses Fundraising Goal
October 10, 2024 16:40 ET
|
Claire's Place Foundation
Los Angeles, CA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is thrilled to...
10th Annual Glow Ride for Cystic Fibrosis: Claire’s Place Foundation Shines Brighter Than Ever
September 05, 2024 08:15 ET
|
Claire's Place Foundation
Los Angeles, CA, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is excited to...
BlackLine Announces Participation in Upcoming Investor Conference
September 04, 2024 16:15 ET
|
BlackLine, Inc.
LOS ANGELES, Sept. 04, 2024 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL) today announced that BlackLine’s management team will participate in the following upcoming investor conference: Piper...
Claire’s Place Foundation Partners with Woojer to Launch SICK BEATS
June 21, 2021 12:39 ET
|
Claire's Place Foundation
Los Angeles, CA, June 21, 2021 (GLOBE NEWSWIRE) -- Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is pleased to...
Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
May 06, 2021 16:13 ET
|
Translate Bio, Inc.
-- Advanced infectious disease vaccine programs with Sanofi Pasteur through initiation of COVID-19 clinical trial and publication of preclinical results; Influenza trial anticipated to begin mid-year...
Translate Bio Announces Key Leadership Additions and Promotions
April 19, 2021 07:30 ET
|
Translate Bio, Inc.
-- Seasoned healthcare executive, Brendan Smith, appointed as Chief Financial Officer, bringingstrategic operations and financial leadership -- -- Appointments enhance capabilities across pulmonary...
Translate Bio Appoints Dr. Rand Sutherland as President
March 22, 2021 07:30 ET
|
Translate Bio, Inc.
-- 20 years of combined industry, medical and academic expertise in pulmonary and rare disease to support continued advancement of mRNA therapeutic pipeline -- LEXINGTON, Mass., March 22, 2021 ...
Translate Bio Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis (CF)
March 17, 2021 16:05 ET
|
Translate Bio, Inc.
-- First inhaled mRNA therapeutic delivered in multiple doses to the lungs of CF patients is generally safe and well tolerated; no observed pattern of increases in ppFEV1 -- -- Data supports...
Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress
February 25, 2021 16:05 ET
|
Translate Bio, Inc.
-- Additional interim data expected in early Q2 from Phase 1/2 clinical trial of MRT5005 for the treatment of cystic fibrosis (CF) -- -- Two infectious disease mRNA vaccine programs expected to enter...
Translate Bio Announces Timing of Interim Results from mRNA Therapeutic Clinical Trial in Patients with Cystic Fibrosis; Data Expected in Early Q2 2021
January 07, 2021 07:30 ET
|
Translate Bio, Inc.
-- MRT5005 is the first clinical-stage mRNA therapeutic with nebulized delivery to the lung and first to be administered in multiple doses for the treatment of a chronic genetic disease -- --...